A new special section now available in The Journal of Pharmacology and Experimental Therapeutics highlights emerging evidence showing that non-coding RNAs play a fundamental role in human health and disease.
Entitled “Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools”, this special section includes 15 featured review and original articles contributed by world renowned experts. The section focuses on their most important discoveries on non-coding RNAs and outlining their actual applications in the clinical scenario.
Overall, these articles represent an overview of the latest advancement of basic, translational and clinical research on non-coding RNAs, shedding light on their crucial roles as biomarkers of human disorders—including cancer and cardiovascular disease—and their successful applications in innovative therapeutic strategies.
All content on “Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools” is available in The Journal of Pharmacology and Experimental Therapeutics, January 2023 (384/1) issue and is freely accessible through June 2023.